UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): March 29, 2018

Purple Innovation, Inc.

(Exact Name of Registrant as Specified in its Charter)

Registrant’s telephone number, including area code: (801) 756-2600

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b–2 of the Securities Exchange Act of 1934 (§ 240.12b–2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On March 29, 2018, Purple Innovation, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the staff of Nasdaq (the “Staff”) has determined that the Company has not demonstrated that it meets the minimum 400 round lot holder requirement for initial listing of its warrants set forth in Nasdaq Listing Rule 5515(a)(4) following the completion of the Company’s business combination on February 2, 2018.

The Notice provides that unless the Company requests an appeal of the Staff’s determination to a Nasdaq Hearings Panel (the “Panel”), the Company’s warrants will be scheduled for delisting from Nasdaq and will be suspended at the opening of business on April 9, 2018, after which Nasdaq will remove the Company’s warrants from listing and registration on Nasdaq.

The Company intends to appeal the Staff’s determination by submitting a timely request for a hearing, and to present at the hearing the Company’s plan to demonstrate compliance with the round lot holder requirement with respect to its warrants and, if necessary, to request an extension of time within which to do so. The request for a hearing will stay any suspension of trading in the Company’s warrants on Nasdaq pending the issuance of the Panel’s decision following the hearing and the expiration of any extension granted by the Panel. If the Company’s appeal is not successful, trading in the Company’s warrants on Nasdaq will be suspended, and the Company’s warrants will be removed from listing and registration on Nasdaq. If the Company’s warrants are delisted and deregistered from Nasdaq, the warrants may be eligible for quotation on the OTC Bulletin Board or on the OTC Pink Market. If the Company’s appeal is successful, trading in the Company’s warrants will continue on Nasdaq.

The shares of the Company’s Class A common stock will continue to trade on Nasdaq regardless of the Panel’s decision on the continued listing of the warrants following the hearing.

Safe Harbor Statement

This Current Report on Form 8-K includes forward-looking statements. All statements, other than statements of historical facts, included in this report that address activities, events or developments that the Company expects or anticipates will or may occur in the future are forward-looking statements. These statements are based on certain assumptions and analyses made by the Company in light of current conditions and expected future developments as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform to the Company’s expectations and predictions is subject to a number of risks and uncertainties, including the risk that the Company’s appeal of the Staff’s determination will not be successful, and that as a result the Company’s warrants will be delisted and deregistered from Nasdaq.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.